Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain
This study highlights the importance of administration frequency in basal insulin treatment decisions when glycemic control is held constant. Participants indicated a preference for OW injection frequency, suggesting fewer injections may reduce the burden of insulin administration. These insights support clinical consideration of less frequent injections when making T2D treatment decisions.
Authors
- Elisabeth de Laguiche (ORCID: https://orcid.org/0000-0003-2125-9006)
- Claire Mottershead
- Lewis Ormerod
- Amy Jones (ORCID: https://orcid.org/0000-0003-3645-746X)
- Pam Hallworth
- H. Kendal
- Virginia Bellido
- Diogo Belbute
- Clémence Antier
- Virginia Pascual
Institutions
- Novo Nordisk (Denmark) (DK)
- Adelphi Group (United Kingdom) (GB)
- Novo Nordisk (United States) (US)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1111/dom.70422
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Diabetes Canada
- Novo Nordisk